These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 326112

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effects of intermittent positive pressure ventilation on lung function in hyaline membrane disease.
    Harrison VC, Heese HD, Klein M.
    Br J Anaesth; 1969 Nov; 41(11):908-17. PubMed ID: 4901337
    [No Abstract] [Full Text] [Related]

  • 5. Serial studies of lung volume and VA-Q in hyaline membrane disease.
    Tori CA, Krauss AN, Auld PA.
    Pediatr Res; 1973 Feb; 7(2):82-8. PubMed ID: 4688500
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease.
    Normand IC.
    Bull Physiopathol Respir (Nancy); 1973 Feb; 9(6):1473-94. PubMed ID: 4602246
    [No Abstract] [Full Text] [Related]

  • 9. Surfactant deficiency in hyaline membrane disease: the story of discovery.
    Avery ME.
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1074-5. PubMed ID: 10764292
    [No Abstract] [Full Text] [Related]

  • 10. Respiratory distress syndrome: the preventive use of glucocorticoids.
    Haller CC, King CR.
    J Kans Med Soc; 1981 Mar; 82(3):98-106. PubMed ID: 6895085
    [No Abstract] [Full Text] [Related]

  • 11. The prevention of hyaline membrane disease: new concepts and approaches to therapy.
    Farrell PM, Kotas RV.
    Adv Pediatr; 1976 Mar; 23():213-69. PubMed ID: 795280
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 50 Years Ago in TheJournal ofPediatrics.
    Dunn MS.
    J Pediatr; 2016 Jul; 174():22. PubMed ID: 27346503
    [No Abstract] [Full Text] [Related]

  • 15. What is new in our understanding of perinatal pulmonary problems? Presidential address to the Society for Pediatric Research, May 19, 1973.
    Avery ME.
    Pediatr Res; 1973 Oct; 7(10):842-5. PubMed ID: 4583722
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of prematurity and hyaline membrane disease on oxygen exchange in the lung.
    Woodrum DE, Oliver TK, Hodson WA.
    Pediatrics; 1972 Sep; 50(3):380-6. PubMed ID: 5056411
    [No Abstract] [Full Text] [Related]

  • 18. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R, Uszyński M.
    Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
    [No Abstract] [Full Text] [Related]

  • 19. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature].
    Gandibleux-Bergiers MF.
    J Gynecol Obstet Biol Reprod (Paris); 1982 Dec; 11(5):625-37. PubMed ID: 6757311
    [Abstract] [Full Text] [Related]

  • 20. Effects of oxygen and constant positive pressure breathing on aADCO2 in hyaline membrane disease.
    Hansen TN, Corbet AJ, Kenny JD, Courtney JD, Rudolph AJ.
    Pediatr Res; 1979 Oct; 13(10):1167-71. PubMed ID: 388333
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.